Minnema M, Nasserinejad K, Hazenberg B, et al. HOVON 104: results from a multicenter, prospective phase II study of bortezomib based induction treatment followed by autoogous stem cell transplantation in patients with de novo AL amyloidosis. EHA 2017, abstract S411.
IJzer Expertise Centrum gaat van Radboudumc over naar Sanquin
mrt 2021 | Benigne hematologie